Should I take CVC or customer money — and what does it do to my acquirer list?

You will be offered money by a company that could also be your customer, your channel, or your acquirer, and it will be pitched as all three. Until a separate commercial agreement makes it something else, it is a check. What follows is what strategic money has actually bought the companies we have watched, and what it has cost them.

Strategic money is money, not a relationship.

You will reserve an allocation for a corporate investor because of what the relationship promises. In the companies we have watched, the check alone bought a headline and no distribution, and the integrations that produced revenue were signed on their own paper, with dates and a named owner. The venture arm and the business unit that would sell or buy your product are different organizations with different incentives, and the check does not move the second one.

If you take strategic money, negotiate the commercial relationship as a separate agreement at the same time, with dates, obligations, and a named person on the business-unit side. Better still, build the integration first and let the investment follow the evidence. The reverse order, money first and integration promised, buys nothing.

It is not a round until the money arrives.

A corporate investor's term sheet feels more validating than a fund's, because of the commercial endorsement it implies. On timing risk it is strictly worse. A corporate investment committee is a corporate committee, and it meets on the corporation's calendar, which is not yours. The negotiation can take quarters of a founder's time and produce observer seats and price concessions before it produces a wire, and a corporate investor that walks away late pays nothing for it. The endorsement is usually not attached to anyone who can act on it. Treat a corporate investor's term sheet as real on the day the money arrives, and run the round as if it might not.

Your acquirer list narrows when you sign.

The exit feels years away, and the check changes it now. A rival's venture arm on your cap table narrows your acquirer list to buyers who are comfortable owning what a rival holds, and most are not. Information rights mean a corporate investor that competes across security receives your quarterly numbers, and that is the same document its product team reads. A right of first refusal or a right to be notified of a sale, however softly worded, tells every other acquirer that the deal has a spectator. Price all of that before the round, because at the exit none of it is negotiable.

Customer money is a discount that never expires.

A customer or a design partner will ask for equity or warrants instead of payment, and the request comes dressed up as commitment. It is structure plus a disclosure problem inside their own procurement. The discount never expires, the conflict is theirs to disclose and yours to explain, and the account can no longer be counted as recurring revenue, because the buyer now has an interest in the vendor. Design partners pay. If a customer wants exposure and their employer permits it, keep the commercial contract and the investment on separate paper, each with its own end date, and never make one a condition of the other.

Ask what separates money from a relationship.

You ask these before you take either. Who on the business side owns the mandate, and what happens to the relationship if that person leaves. Which information rights they want, and what their product team will be able to see. Whether they will sign a standstill and waive any rights on a sale. Whether the business unit that would actually buy or resell your product knows the venture arm is investing. If every answer comes from corporate development alone, the check is money. Take it as money, or do not take it.

When it is right.

You take strategic money when the integration already exists and is producing revenue, when the check comes with no rights beyond what a fund would get, when the business unit is the sponsor and its leader is on the call, and when your acquirer list is already narrow enough that one more spectator changes nothing. Then the corporate investor is a customer buying a small piece of the upside, which is a fine thing to sell. Everything else is a headline you will pay for at the exit.